PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34899152-0	2021	AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China.	Valproic Acid	92-105	arsenite methyltransferase	Homo sapiens	0-5	
34899152-11	2021	Carriers of AS3MT rs7085104 AA genotype exhibited a higher risk of digestive adverse drug reactions (dADRs) in children when treated with valproic acid (VPA) or oxcarbazepine (OXC).	Valproic Acid	138-151	arsenite methyltransferase	Homo sapiens	12-17	
34899152-11	2021	Carriers of AS3MT rs7085104 AA genotype exhibited a higher risk of digestive adverse drug reactions (dADRs) in children when treated with valproic acid (VPA) or oxcarbazepine (OXC).	Valproic Acid	153-156	arsenite methyltransferase	Homo sapiens	12-17	
34899152-12	2021	Additionally, bioinformatics analysis identified eight AS3MT target genes related to epilepsy and three AS3MT-associated genes in VPA-related dADRs.	Valproic Acid	130-133	arsenite methyltransferase	Homo sapiens	104-109